Central Nervous System
Access broad and deep neurology expertise to reduce costs, accelerate timelines and manage risk, from clinical trials to evidence generation and beyond.
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases & Vaccines
- Oncology & Hematology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSFEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI®
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESBlog
Collaborative Partnership Between IQVIA and TRICALS
Aug 28, 2025
Amyotrophic Lateral Sclerosis (ALS), also known as motor neurone disease (MND) or Lou Gehrig’s Disease (LGD) in the US, is a progressive neurodegenerative disease. Although relatively rare, with 2 new cases per 100,000 people each year, its impact is devastating, profoundly affecting patients and their families. There is currently no known cure, but significant advances in promising novel treatments offer hope.
IQVIA, a leading global provider of clinical research services, commercial insights, and healthcare intelligence, has partnered with TRICALS (Treatment Research Initiative to Cure ALS), the largest European research initiative aimed at finding a cure for ALS. This collaboration combines TRICALS’ scientific knowledge and extensive site network with IQVIA’s data, science, and operational capabilities to develop new medicines for ALS.
A cornerstone of this effort is the MAGNET initiative (Multi-Adaptive Global Network of ALS Clinical Trials), which offers a full-service solution for conducting Phase II and III ALS trials within a competitive budget.
The MAGNET initiative builds on the strength of TRICALS and IQVIA as a preferred CRO to enable the following:
- Input from the TRICALS network of over 60 certified centres to help design and perform your study, including insights from patient organizations
- Innovative template protocol designs, with design elements approved in advance by regulatory authorities, ensuring studies are designed in the optimal way while offering flexibility of approach
- Start-up efficiencies through working with the existing TRICALS infrastructure, including contract templates and budgets designed to streamline study set-up
- The promise of recruitment delivery through the specialist centres that form the TRICALS network, supported by IQVIA in enabling operational delivery
As well as the provision of clinical trial management, IQVIA is proud to have been the global partner supporting TRICALS in the development of their ‘Precision ALS’ platform. This innovative platform facilitates the collection and utilization of incident and prevalent patient data across the extensive network of TRICALS research sites , providing critical insights into the ALS population and accelerating the journey towards effective treatments. PRECISION ALS revolutionizes the way patient data is gathered and utilized , and by leveraging IQVIA’s vast global experience in healthcare data analytics, the Precision ALS platform will provide new insights into the heterogeneity of ALS, develop better markers of different disease subtypes, better data-driven outcome measures, better insights into important social determinants of health that affect disease risk and outcome, and provide new ways to match the right patient to the right drug in a clinical trial setting. The platform, in research collaboration with IQVIA,will continue to support TRICALS in ensuring that all patient data is utilized responsibly and in full compliance with all relevant legislation and data protection standards.
Additional Key Areas of Collaboration:
- Optimizing Study Designs and Research Protocols: IQVIA’s strategic drug development experience and global operational capabilities, combined with TRICALS’ academic expertise, ensure that study protocols are optimally designed to address key questions related to the ALS patient population.
- Supporting More Clinical Research Sites: While TRICALS collaborates with over 60 research centers in 17 European countries, IQVIA brings its operational experience in supporting these sites, enabling research teams to be ‘trial ready’ and ensuring consistency of approach through training and education.
- Efficiently Operationalizing Clinical Trial Programs: IQVIA, as a leading CRO with extensive experience in running global clinical trial programs, including in the field of ALS, will support TRICALS in efficiently operationalizing these programs, delivering quality study results that will serve as the basis for market authorizations of new and innovative treatments. Furthermore, IQVIA and TRICALS will work in partnership to conduct scientific discussion forums where developments in the field of ALS can continue to be explored.
The collaboration between IQVIA and TRICALS aims to bring together data and ALS-specific business intelligence to deliver optimal strategies and solutions for the ALS population, advancing clinical research in this field. This partnership will support industry sponsors by enabling them to develop tailor-made strategies through insights derived from the ALS patient population. Ultimately, this collaboration will support sponsors in developing potential treatments more quickly and cost-effectively, bringing the goal of a treatment for ALS closer to reality.